PRP guidelines · International

Efficacy of Ultrasound-Guided Glenohumeral Joint Injections of Leukocyte-Poor Platelet-Rich Plasma Versus Hyaluronic Acid in the Treatment of Glenohumeral Osteoarthritis: A Randomized, Double-Blind Controlled Trial

Jonathan S Kirschner, Jennifer Cheng, Andrew Creighton, Kristen Santiago, Nicole Hurwitz, Mark Dundas, Nicholas Beatty, Dallas Kingsbury, Gabrielle Konin, Zafir Abutalib, Richard Chang

Clinical Journal of Sport Medicine · 2022

In brief

Researchers ran a double-blind randomised controlled trial of a single ultrasound-guided shoulder joint injection of leukocyte-poor platelet-rich plasma (PRP) versus hyaluronic acid for glenohumeral (shoulder) osteoarthritis. Over a year, patients in both groups improved in pain and function, but the authors found no meaningful difference between the two treatments.

Read the original paper (opens in a new tab)

Citation, as listed in the PRP guidelines

Efficacy of Ultrasound-Guided Glenohumeral Joint Injections of Leukocyte-Poor Platelet-Rich Plasma Versus Hyaluronic Acid in the Treatment of Glenohumeral Osteoarthritis: A Randomized, Double-Blind Controlled Trial Authors: Jonathan S Kirschner, Jennifer Cheng, Andrew Creighton, Kristen Santiago, Nicole Hurwitz, Mark Dundas, Nicholas Beatty, Dallas Kingsbury, Gabrielle Konin, Zafir Abutalib, Richard Chang Link: https://pubmed.ncbi.nlm.nih.gov/35316820/ Year of Publication: 2022

A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.

More from the PRP guidelines

Ready to rewrite your health story?

Request a callback from our team.